A study by Yale School of Medicine reveals that survival rates for patients with a thoracic aneurysm are significantly better, and complications are fewer, among patients who take statin cholesterol drugs than those who do not. The study appears in the American Journal of Cardiology.
- Social Sciences - Apr 22 Focus of Penn Researcher Leads to National Summit on Youth Aging Out of Foster Care
- Life Sciences - Apr 22 Penn Bioinformatics Profiling Identifies a New Mammalian Clock Gene
- Environmental Sciences - Apr 22 UAlberta one of Canada’s Greenest Employers for sixth straight year April 22, 2014 Green award recognizes leadership in creating culture of environmental awareness
- Literature - Apr 22 'A rarity most beloved': Shakespeare folios on display
- Chemistry - Apr 22 Cornell's chemically engineered cars win again
- Life Sciences - Apr 22 New alfalfa variety resists ravenous local pest
- Arts - Apr 22 Stanford Live posts 2014-15 season performances
- Life Sciences - Apr 22 Scientists observe brain activity in real time
- Environmental Sciences - Apr 22 Birding Cup, Native Plant Festival take flight at Shaver’s Creek on May 2 and 3
- History - Apr 22 Exhibit explores the art and science of bones found on the Green
- Life Sciences - Apr 22 'OMG GMO' will look at the science behind genetically modified food
Statins may protect against death from aneurysm, Yale study finds
An aneurysm is a swelling of an artery, and is a common cause of death. It’s usually asymptomatic, with death or a life-threatening complication such as rupture or dissection being the first manifestation. Statins are cholesterol-lowering drugs that are widely used in patients with cardiovascular disease.
Assistant professor of cardiothoracic surgery Ion S. Jovin, M.D., and colleagues studied 649 patients with thoracic aortic aneurysms: 147 were taking statins and 502 were not. In long-term follow-up 80% of those taking statins survived, compared with 67% percent of those not taking statins. In addition, a smaller percentage of those taking statins suffered a rupture or dissection (splitting of the aorta), compared to those who were not taking statins.
"The intake of statins was associated with an improvement in long-term outcomes among these patients," said co-author John Elefteriades, M.D., professor of cardiothoracic surgery at Yale School of Medicine and director of the Aortic Institute at Yale-New Haven Hospital. "In addition to better survival, fewer patients taking statins required surgical intervention," Elefteriades added.
Medical science has searched for decades for a medicine that could treat aneurysm disease, with little success. The current standard therapy is to keep blood pressure low to discourage rupture of the enlarged artery. Jovin said his research suggests that "statins could offer a significant protective effect to patients at risk of death or complications from aneurysm disease. However, the ultimate proof would be a randomized clinical trial." Elefteriades adds, "We now have some arrows in our quiver of medicines to treat this disease."
Other authors are Mona Duggal, Keita Ebisu, Hyung Paek, A. Dana Oprea, Maryann Tranquilli, John Rizzo, Redin Memet, Marina Feldman, James Dziura, and Cynthia A. Brandt of Yale.
Last job offers
- Medicine - 23.4
Asst/Assoc / Professor of Clinical Medicine (Infectious Disease)
- Medicine - 23.4
Assistant / Associate Professor - Pediatric Emergency Medicine
- Psychology - 22.4
Tenure-related Open Rank Faculty Position
- Life Sciences - 22.4
Assistant Professor / Faculty Position
- Medicine - 21.4
Assistant / Associate/Full Professor of Clinical Neurosurgery
- Medicine - 21.4
Associate or Full Professor
- Medicine - 19.4
- Medicine - 18.4
Infectious Diseases ct Faculty Position